NorthWest Biotherapeutics Inc (NWBO)

[Bacchus1]

I think when we had the jump to $2.50, everyone got excited over the Flaskworks acquisition and we had data lock. Naturally we expected this to be followed by TLD. As time goes on, there is very little movement in terms of trading volume and the MMs are keeping a lid on the SP.

Us longs are holding on because we believe in the science and expect the data to show that DCVax shows a significant improvement compared to SOC in this awful disease. At the end of the day, the SP is irrelevant to those of us who do not trade every day for a few cents per share.

The only thing that really matters is that this treatment is approved and available for patients who need it. The rise in SP +/- BO/merger will follow. Direct will be developed imo and this will be a game changer in the treatment of cancer.